Serkan Dikici

Dr. Serkan Dikici

Department of Materials Science and Engineering, Kroto Research Institute, University of Sheffield, Sheffield S3 7HQ, United Kingdom
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2019 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
NMNaside Mangir
Naside Mangir
Serkan DikiciSerkan Dikici
Serkan Dikici
FCFrederik Claeyssens
Frederik Claeyssens
SMSheila MacNeil
Sheila MacNeil

20 August 2019 in Materials
Verified
Journal Article
Open access
PDF file
Betül Aldemir DikiciBetül Aldemir Dikici
Betül Aldemir Dikici
Serkan DikiciSerkan Dikici
Serkan Dikici
Gwendolen ReillyGwendolen Reilly
Gwendolen Reilly
SMSheila Macneil
Sheila Macneil
Frederik ClaeyssensFrederik Claeyssens
Frederik Claeyssens
Guided bone regeneration is a common dental implant treatment where a barrier membrane (BM) is used between epithelial tissue and bone or bone graft to prevent the invasion of the fast-proliferating epithelial cells into the defect site to be able to preserve a space for infiltration of slower-growing bone cells into the periodontal defect site. In this study, a bilayer polycaprolactone (PCL) BM was developed by combining electrospinning and emulsion templating techniques. First, a 250 µm thick polymerised high internal phase emulsion (polyHIPE) made of photocurable PCL was manufactured and treated with air plasma, which was shown to enhance the cellular infiltration. Then, four solvent compositions were investigated to find the best composition for electrospinning a nanofibrous PCL barrier layer on PCL polyHIPE. The biocompatibility and the barrier properties of the electrospun layer were demonstrated over four weeks in vitro by histological staining. Following in vitro assessment of cell viability and cell migration, cell infiltration and the potential of PCL polyHIPE for supporting blood vessel ingrowth were further investigated using an ex-ovo chick chorioallantoic membrane assay. Our results demonstrated that the nanofibrous PCL electrospun layer was capable of limiting cell infiltration for at least four weeks, while PCL polyHIPE supported cell infiltration, calcium and mineral deposition of bone cells, and blood vessel ingrowth through pores.

16 July 2019 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
PDF file
Serkan DikiciSerkan Dikici
Serkan Dikici
FCFrederik Claeyssens
Frederik Claeyssens
SMSheila MacNeil
Sheila MacNeil
Although significant progress has been made, delayed neovascularisation of tissue-engineered constructs still remains challenging for the survival of constructs post-grafting. The addition of laboratory expanded proangiogenic cells to tissue engineering scaffold systems prior to implantation is a promising approach to overcome the slow neovascularisation. The use of decellularised biological constructs is an emerging strategy for producing physiologically relevant scaffolds for use in both pre-clinical and clinical applications. Decellularised plant architectures have recently been proposed as one approach – here we seek to confirm and extend this work by preparing baby spinach leaves without damaging their intrinsic vascular architecture and to explore their efficacy once seeded with cells to promote neovascularisation in a chick bioassay of neovascularisation. Firstly, the in vitro biocompatibility of the decellularised spinach leaves and the effect of gelatin coating on cell attachment and proliferation were assessed. The decellularised leaves showed no toxicity to cells, and gelatin coating and the presence of fibroblasts enhanced the survival of human endothelial cells in the scaffolds. The proangiogenic activity of these cell populated scaffolds was then investigated in ex ovo chick chorioallantoic membrane assay where the presence of the endothelial cells significantly promoted angiogenesis over seven days. In conclusion, these results support a small but growing body of literature that suggests the use of decellularised plants as potential scaffolds to promote neovascularisation for tissue engineering constructs.

3 November 2021 in Biomacromolecules
Verified
Journal Article
Closed access
Betül Aldemir DikiciBetül Aldemir Dikici
Betül Aldemir Dikici
AMAtra Malayeri
Atra Malayeri
CSColin Sherborne
Colin Sherborne
Serkan DikiciSerkan Dikici
Serkan Dikici
TPThomas Paterson
Thomas Paterson
Frederik ClaeyssensFrederik Claeyssens
Frederik Claeyssens

29 April 2020 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
Serkan DikiciSerkan Dikici
Serkan Dikici
Frederik ClaeyssensFrederik Claeyssens
Frederik Claeyssens
SMSheila Macneil
Sheila Macneil
Angiogenesis assays are essential for studying aspects of neovascularisation and angiogenesis and investigating drugs that stimulate or inhibit angiogenesis. To date, there are several in vitro and in vivo angiogenesis assays that are used for studying different aspects of angiogenesis. Although in vivo assays are the most representative of native angiogenesis, they raise ethical questions, require considerable technical skills, and are expensive. In vitro assays are inexpensive and easier to perform, but the majority of them are only two-dimensional cell monolayers which lack the physiological relevance of three-dimensional structures. Thus, it is important to look for alternative platforms to study angiogenesis under more physiologically relevant conditions in vitro. Accordingly, in this study, we developed polymeric vascular networks to be used to study angiogenesis and vascularisation of a 3D human skin model in vitro. Our results showed that this platform allowed the study of more than one aspect of angiogenesis, endothelial migration and tube formation, in vitro when combined with Matrigel®. We successfully reconstructed a human skin model, as a representative of a physiologically relevant and complex structure, and assessed the suitability of the developed in vitro platform for studying endothelialisation of the tissue-engineered skin model.

17 January 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
Serkan DikiciSerkan Dikici
Serkan Dikici
Betül Aldemir DikiciBetül Aldemir Dikici
Betül Aldemir Dikici
SBShirin Issa Bhaloo
Shirin Issa Bhaloo
MBMercedes Balcells
Mercedes Balcells
Elazer R. EdelmanElazer R. Edelman
Elazer R. Edelman
FCFrederik Claeyssens
Frederik Claeyssens
Angiogenesis is a highly ordered physiological process regulated by the interaction of endothelial cells with an extensive variety of growth factors, extracellular matrix components and mechanical stimuli. One of the most important challenges in tissue engineering is the rapid neovascularization of constructs to ensure their survival after transplantation. To achieve this, the use of pro-angiogenic agents is a widely accepted approach. The study of angiogenesis has gained momentum over the last two decades. Although there are various in vitro, ex vivo, and in vivo angiogenesis models that enable testing of newly discovered pro-angiogenic agents, the problem with researching angiogenesis is the choice of the most appropriate assay. In vivo assays are the most representative and reliable models, but they are expensive, time-consuming and can cause ethical concerns whereas in vitro assays are relatively inexpensive, practical, and reproducible, but they are usually lack of enabling the study of more than one aspect of angiogenesis, and they do not fully represent the complexity of physiological angiogenesis. Therefore, there is a need for the development of an angiogenesis model that allows the study of angiogenesis under physiologically more relevant, dynamic conditions without causing ethical concerns. Accordingly, in this study, we developed 3D in vitro dynamic angiogenesis model, and we tested the angiogenic potential of 2-deoxy-D-ribose (2dDR) in comparison with vascular endothelial growth factor (VEGF) using newly developed in vitro 3D dynamic model and well-established in vitro models. Our results obtained using conventional in vitro assays demonstrated that 2dDR promoted proliferation, migration and tube formation of human aortic endothelial cells (HAECs) in a dose-dependent manner. Then, the angiogenic activity of 2dDR was further assessed using the newly developed 3D in vitro model, which enabled the monitoring of cell proliferation and infiltration simultaneously under dynamic conditions. Our results showed that the administration of 2dDR and VEGF significantly enhanced the outgrowth of HAECs and the cellular density under either static or dynamic conditions.